Physician profile
Michael Yandel
NPI 1578664140
$2,908.49
in general payments reported to CMS, 2019-2025
28 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $340 · 2021: $592 · 2022: $778 · 2023: $49.48 · 2024: $321 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $500.12 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $265.32 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $255.38 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $210.77 | 2019-2022 | |
| Shockwave Medical, INC | $187.50 | 2021 | |
| Abbott Laboratories | $185.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $171.09 | 2019-2022 | |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Pfizer INC. | $116.61 | 2019-2024 | |
| Boston Scientific Corporation | $109.87 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.13 | 2019 | |
| W. L. Gore & Associates, INC. | $96.00 | 2021 | |
| Merck Sharp & Dohme LLC | $87.02 | 2022-2023 | Verquvo |
| Bard Peripheral Vascular, INC. | $60.05 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $53.40 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $52.44 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $45.35 | 2022 | |
| Lundbeck LLC | $40.50 | 2019-2020 | |
| Cardiva Medical, INC. | $38.38 | 2022 | |
| Sanofi-Aventis U.S. LLC | $37.59 | 2019 | |
| Medtronic Vascular, INC. | $31.40 | 2019 | |
| Teleflex LLC | $30.66 | 2025 | Orsiro Mission |
| Angiodynamics, INC. | $26.87 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Amarin Pharma, INC. | $23.92 | 2020 | |
| Cardiovascular Systems INC. | $17.25 | 2022 | |
| Biosense Webster, INC. | $15.07 | 2022 | |
| Argon Medical Devices, INC. | $14.41 | 2022 | |
| Gilead Sciences, INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yandel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.